Supplier Type
- Manufacturer
- Trader
- custom synthesis
- contract manufacturer
- Reagent
Supplier Region
- Maharashtra(17)
- Gujarat(21)
- New Delhi(2)
- Andhra Pradesh(1)
- Hyderabad(14)
- Bangalore(2)
- Telangana(1)
- Pune(2)
- Vadodara(5)
- Mumbai(22)
- Ahmedabad(8)
- Karnataka(6)
- Uttar Pradesh(4)
- Beijing(1)
- Rajasthan(1)
- Delhi(7)
- Tamil Nadu(2)
- Kolkata(2)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT 95%
- NLT 90%
- More than 98%
- more than 95%
- more than 90%
- MINIMUM 99%
- Min 98 %
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Manganese content Min. 31.85%
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- Content of Copper Min. 29.5%
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.98%
- 99.95%
- 99.91%
- 99.88%
- 99.86%
- 99.85%
- 99.84%
- 99.81%
- 99.80%
- 99.73%
- 99.70%
- 99.69%
- 99.61%
- 99.47%
- 99.42%
- 99.40%
- 99.39%
- 99.29%
- 99.28%
- 99.27%
- 99.21%
- 99.19%
- 99.10%
- 99.00%
- 99.0%-101.5%
- 99.0%
- 99% min
- > 99%
- 99%
- >99%
- 98=%
- 98+
- 98.94%
- 98.88%
- 98.65%
- 98.60%
- 98.54%
- 98.53%
- 98.50%
- 98.5
- 98.34%
- 98.18%
- 98.12%
- 98.08%
- 98.00%
- 98% Min.
- 98% Min
- 98%
- 98 - 102%
- 97-99%
- 97.61%
- 97.57%
- > 97.5 %
- 97.00%
- 97% min
- 97%
- >97%
- 97 %
- 96.80%
- 96.5 - 103.5 %
- 96.40%
- 96.39%
- 96%
- 95-98%
- 95.16%
- 95.00%
- 95%
- >95%
- 94.34%
- 94.00%
- 93 %- 101%
- 92-95%
- >92%
- 91.87%
- 90%-95%
- 90%
- >90%
- 90 % Above
- 84.49%
- 36.0 to 42.0%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- 0.04%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 100mg
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 0Customized pack size availaible
- 25mg
- 50mg
- 250mg
- 500mg
- 1g
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100g
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 1and gm
- 95NLT %
- 250250 mg.
- 11Between 1 gm to 1 MT (As per availability)
-
Formoterol EP Impurity C
1795135-61-3
-
Sodium Stearyl Fumarate
4070-80-8
-
Quetiapine fumarate
111974-72-2
-
Vonoprazan fumarate
1260141-27-2
-
Rupatadine Fumarate
182349-12-8
-
((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone
1103738-19-7
-
6-HYDROXY-2,4,5-TRIAMINOPYRIMIDINE SULFATE
39267-74-8
-
4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
150728-13-5
-
Cyclopropylacetylene
6746-94-7
-
1,2,4-Triazole
288-88-0
Formoterol EP Impurity C 1795135-61-3
Quetiapine fumarate 111974-72-2
Vonoprazan Fumarate 1260141-27-2
(5S)-D-xylo-Pentodialdo-5,2-furanose, 4,5-O-(1-Methylethylidene)-1-C-4-Morpholinyl 1103738-19-7
Quetiapine fumarate 111974-72-2
6-Hydroxy-2,4,5-triaminopyrimidine sulfate 39267-74-8
4,5,6,7-Tetrahydrothieno[3,2,c]pyridine hydrochloride 28783-41-7
Sodium stearyl fumarate 4070-80-8
Ferrous fumarate 141-01-5